SOLIGENIX, INC. 3Q 2026: Revenue $0 EPS $(0.12) — 10-Q SummaryTradingView·Aug 7 at 03:11 PMSNGX+0.87%
Soligenix Announces Recent Updates and Second Quarter 2026 Financial ResultsUnusual Whales·Aug 7 at 06:56 AMSNGX+0.87%
Soligenix increases at-the-market offering by additional $2.5 millionPUBT·Jun 26 at 03:07 PMSNGX+0.87%
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak | AEMD Stock NewsStockTitan·Jun 25 at 10:00 PMSNGX+0.87%AEMD+0.72%
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine | SNGX Stock NewsStockTitan·Jun 7 at 10:30 PMSNGX+0.87%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jun 3 at 12:06 PMPIII+2.82%SNGX+0.87%
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·Jun 3 at 07:06 AMABVX-3.14%SNGX+0.87%
